AZD5363 (ipatasertib)

ipatasertib · AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AZD5363 (ipatasertib), covering 2014-06-19 to 2014-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. [Phase 1]